SK6752002A3 - Novel thiazolidinedione derivatives as antidiabetic agents - Google Patents

Novel thiazolidinedione derivatives as antidiabetic agents Download PDF

Info

Publication number
SK6752002A3
SK6752002A3 SK675-2002A SK6752002A SK6752002A3 SK 6752002 A3 SK6752002 A3 SK 6752002A3 SK 6752002 A SK6752002 A SK 6752002A SK 6752002 A3 SK6752002 A3 SK 6752002A3
Authority
SK
Slovakia
Prior art keywords
ethoxy
benzyl
dione
amino
compound
Prior art date
Application number
SK675-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Mancini Marisabel Mourelle
Castillo Nieto Juan Carlos Del
Ramon Amat Elisabet De
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Publication of SK6752002A3 publication Critical patent/SK6752002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK675-2002A 1999-11-18 2000-11-15 Novel thiazolidinedione derivatives as antidiabetic agents SK6752002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902533A ES2156574B1 (es) 1999-11-18 1999-11-18 Nuevos derivados de tiazolidindiona como agentes antidiabeticos
PCT/ES2000/000432 WO2001036416A1 (es) 1999-11-18 2000-11-15 Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Publications (1)

Publication Number Publication Date
SK6752002A3 true SK6752002A3 (en) 2002-09-10

Family

ID=8310628

Family Applications (1)

Application Number Title Priority Date Filing Date
SK675-2002A SK6752002A3 (en) 1999-11-18 2000-11-15 Novel thiazolidinedione derivatives as antidiabetic agents

Country Status (37)

Country Link
US (1) US7001910B1 (xx)
EP (1) EP1231211B1 (xx)
JP (1) JP2003514817A (xx)
KR (1) KR100518110B1 (xx)
CN (1) CN1159314C (xx)
AP (1) AP1330A (xx)
AR (1) AR031080A1 (xx)
AT (1) ATE241622T1 (xx)
AU (1) AU770045B2 (xx)
BG (1) BG106699A (xx)
BR (1) BR0015613A (xx)
CA (1) CA2391913A1 (xx)
CO (1) CO5261560A1 (xx)
CR (1) CR6640A (xx)
CZ (1) CZ20021654A3 (xx)
DE (1) DE60003072T2 (xx)
DK (1) DK1231211T3 (xx)
EA (1) EA004301B1 (xx)
EE (1) EE200200254A (xx)
ES (2) ES2156574B1 (xx)
GE (1) GEP20043240B (xx)
HR (1) HRP20020426A2 (xx)
HU (1) HUP0203478A2 (xx)
IL (1) IL149634A0 (xx)
IS (1) IS2014B (xx)
MA (1) MA26844A1 (xx)
MX (1) MXPA02005011A (xx)
NO (2) NO20022336L (xx)
NZ (1) NZ519264A (xx)
OA (1) OA12089A (xx)
PE (1) PE20010858A1 (xx)
PL (1) PL354877A1 (xx)
PT (1) PT1231211E (xx)
SK (1) SK6752002A3 (xx)
WO (1) WO2001036416A1 (xx)
YU (1) YU40202A (xx)
ZA (1) ZA200203906B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174748B1 (es) * 2001-01-31 2003-09-16 Vita Lab Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
JP5546372B2 (ja) * 2010-06-30 2014-07-09 積水メディカル株式会社 ベンジルヒダントイン化合物の製造法
WO2016184895A1 (en) 2015-05-18 2016-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Means for detecting or measuring a biological activity of a botulinum toxin
US10689374B1 (en) 2019-07-12 2020-06-23 United Arab Emirates University Pyrimidine-thiazolidinone derivatives
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
DK1231211T3 (da) 2003-10-27
US7001910B1 (en) 2006-02-21
MXPA02005011A (es) 2003-10-14
BR0015613A (pt) 2002-07-23
HUP0203478A2 (hu) 2003-02-28
KR100518110B1 (ko) 2005-10-04
CA2391913A1 (en) 2001-05-25
EP1231211A1 (en) 2002-08-14
NO20022379D0 (no) 2002-05-16
IS2014B (is) 2005-06-15
ES2199878T3 (es) 2004-03-01
IS6386A (is) 2002-05-15
CN1159314C (zh) 2004-07-28
PT1231211E (pt) 2003-09-30
ZA200203906B (en) 2004-03-26
IL149634A0 (en) 2002-11-10
NO20022336L (no) 2002-07-09
EE200200254A (et) 2003-06-16
WO2001036416A1 (es) 2001-05-25
OA12089A (en) 2006-05-04
BG106699A (bg) 2003-02-28
CO5261560A1 (es) 2003-03-31
AR031080A1 (es) 2003-09-10
PL354877A1 (en) 2004-03-08
CN1402724A (zh) 2003-03-12
YU40202A (sh) 2006-01-16
KR20020079737A (ko) 2002-10-19
NO20022336D0 (no) 2002-05-15
MA26844A1 (fr) 2004-12-20
PE20010858A1 (es) 2001-08-22
DE60003072T2 (de) 2004-04-01
NZ519264A (en) 2003-10-31
GEP20043240B (en) 2004-05-25
AP2002002512A0 (en) 2002-06-30
HRP20020426A2 (en) 2004-02-29
AP1330A (en) 2004-11-25
EA200200470A1 (ru) 2002-10-31
JP2003514817A (ja) 2003-04-22
ES2156574A1 (es) 2001-06-16
AU770045B2 (en) 2004-02-12
AU1281501A (en) 2001-05-30
CZ20021654A3 (cs) 2002-09-11
CR6640A (es) 2004-03-05
EA004301B1 (ru) 2004-02-26
EP1231211B1 (en) 2003-05-28
ES2156574B1 (es) 2002-02-01
ATE241622T1 (de) 2003-06-15
DE60003072D1 (de) 2003-07-03

Similar Documents

Publication Publication Date Title
US10000490B2 (en) Inhibitors of the fibroblast growth factor receptor
AU2001242629B2 (en) 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
EP0802914B1 (en) Aryl- and heteroaryl- purine and pyridopyrimidine derivatives
US10752622B2 (en) GPR119 agonist compounds
SK6752002A3 (en) Novel thiazolidinedione derivatives as antidiabetic agents
JP5302540B2 (ja) プロテインキナーゼ阻害剤として有用な２，５及び２，６−二置換ベンザゾール類似体
NZ226027A (en) N-substituted amino ethoxy benzylidene-2,4-thiazolidinedione derivatives and pharmaceutical compositions
US20040229876A1 (en) Quinoline derivatives and quinazoline derivatives having azolyl group
US20070021446A1 (en) 2-arylbenzothiazole analogues and uses thereof
US5599826A (en) Thiazolidinediones and drugs containing them
EP3481819B1 (en) Compounds and their use for reducing uric acid levels
KR100379196B1 (ko) 트리아졸화합물및도파민-d₃리간드로서의그의용도
US7576090B2 (en) Benzazole analogues and uses thereof
US20200338084A1 (en) Inhibitors of low molecular weight protein tyrosine phosphatase (lmptp) and uses thereof
KR100450700B1 (ko) 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
JP2009501164A (ja) ２−アリールベンゾチアゾール及びその使用
US20240216357A1 (en) Polycyclic compound and application thereof